Comparison of serous and mucinous ovarian carcinomas: Distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4

Laboratory Investigation

Volumn 81, Issue 4, 2001, Pages 517-526

  Lassus, Heini ^a   Laitinen, Mika P E ^b   Anttonen, Mikko ^c   Heikinheimo, Markku ^c,d   Aaltonen, Lauri A ^e   Ritvos, Olli ^b   Butzow, Ralf ^a,e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 4;

ALLELE; ARTICLE; CHROMOSOME 8P; CYSTADENOCARCINOMA; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; NORTHERN BLOTTING; OVARY CARCINOMA; OVARY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0035048994     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780260     Document Type: Article

References (44)

1. Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancer
2. Allelic loss of chromosomal arm 8p in breast cancer progression
3. Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines
4. National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
5. Allelic loss on chromosome arm 8p: Analysis of sporadic epithelial ovarian tumors
6. Semiautomated assessment of loss of heterozygosity and replication error in tumors
7. Human epithelial ovarian cancer allelotype
8. Interphase cytogenetic analysis of mucinous ovarian neoplasms
9. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
10. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary
11. Regulation of cardiac gene expression by GATA-4/5/6
12. Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer
13. Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer
14. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene
15. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary
16. Cytogenetic studies of epithelial ovarian carcinoma
17. Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis
18. Tissue microarrays for high-throughput molecular profiling of tumor specimens
19. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
20. Transcription factors GATA-4, GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord derived ovarian tumors
21. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site- amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene
22. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22
23. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer
24. p53 mutation is a common genetic event in ovarian carcinoma
25. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
26. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience
27. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas
28. Chromosome aberrations in 35 primary ovarian carcinomas
29. Genomic alterations in fallopian tube carcinoma: Comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis
30. Genetic alterations distinguish different types of ovarian tumors
31. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study
32. Allelotype of human ovarian cancer
33. Identification of expressed genes by laser-mediated manipulation of single cells
34. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas
35. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family
36. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Mülerian inhibiting substance promoter
37. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21
38. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1
39. Assignment of the transcription factor GATA4 gene to human chromosome 8 and mouse chromosome 14: Gata4 is a candidate gene for Ds (disorganization)
40. Sequence variants of DLC1 in colorectal and ovarian tumours
41. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer
42. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas
43. Allelic loss in ovarian cancer
44. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1